Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 4/2004

01-07-2004 | Letter to the Editor

Sensorineural hearing loss in a patient with ankylosing spondylitis

Authors: Ilker Corapci, Onur Armagan, Funda Tascioglu, Cengiz Öner

Published in: Rheumatology International | Issue 4/2004

Login to get access

Excerpt

The publication of a case report by Sang et al. in which immune-mediated sensorineural hearing loss was observed in a patient with ankylosing spondylitis (AS) prompted us to report this case [1]. We wish to describe a patient with AS, sensorineural hearing loss, and minimal aortic insufficiency whose mother and brother are also human leukocyte antigen (HLA)-B27-positive AS patients. …
Literature
1.
Yeo SW, Park SN (2001) Immune-mediated sensorineural hearing loss in a patient with ankylosing spondylitis: a case report. Otolaryngol Head Neck Surg 125:113–114CrossRefPubMed
2.
Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMed
3.
Magaro M, Ceresia G, Frustaci A (1984). Arthritis and middle ear in ankylosing spondylitis. Ann Rheum Dis 43:658–659PubMed
4.
De Miguel E, Tomas M, Benito S, Gavilan J, Gijon J (1987) Ankylosing spondylitis and middle ear impairment. Ann Rheum Dis 46:174
5.
Raza K, Karokis D, Wilson F, Delamere JP (1998) Sensorineural hearing loss, iritis, and ankylosing spondylitis. Br J Rheumatol 37:1363CrossRefPubMed
Metadata
Title
Sensorineural hearing loss in a patient with ankylosing spondylitis
Authors
Ilker Corapci
Onur Armagan
Funda Tascioglu
Cengiz Öner
Publication date
01-07-2004
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2004
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-003-0425-x

Other articles of this Issue 4/2004

Rheumatology International 4/2004 Go to the issue

Letter to the Editor

Lack of generalizable evidence of the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis: comment on the article by Ringe et al.

Case Report

Differential diagnosis of optic neuritis in a patient with ankylosing spondylitis

Original Article

Serum oxidized low-density lipoproteins in rheumatoid arthritis

Original Article

High prevalence of asymptomatically poor muscle perfusion of lower extremities measured in systemic lupus erythematosus patients with abnormal myocardial perfusion

Original Article

Inhibitory effect of cyclo-oxygenase-2 inhibitor on the production of matrix metalloproteinases in rheumatoid fibroblast-like synoviocytes

Original Article

The Nottingham health profile in rheumatoid arthritis: correlation with other health status measurements and clinical variables
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits